Shandong Weigao Group Medical Polymer Co (Shandong Weigao Group Medical Polymer Co) Total Assets : $4,739 Mil (As of Jun. 2023)

View and export this data going back to 2011. Start your Free Trial

What is Shandong Weigao Group Medical Polymer Co Total Assets?

Shandong Weigao Group Medical Polymer Co's Total Assets for the quarter that ended in Jun. 2023 was $4,739 Mil.

During the past 12 months, Shandong Weigao Group Medical Polymer Co's average Total Assets Growth Rate was -1.70% per year. During the past 3 years, the average Total Assets Growth Rate was 6.30% per year. During the past 5 years, the average Total Assets Growth Rate was 12.00% per year. During the past 10 years, the average Total Assets Growth Rate was 12.60% per year.

During the past 13 years, Shandong Weigao Group Medical Polymer Co's highest 3-Year average Total Assets Growth Rate was 48.10%. The lowest was 1.10%. And the median was 27.55%.

Total Assets is connected with ROA %. Shandong Weigao Group Medical Polymer Co's annualized ROA % for the quarter that ended in Jun. 2023 was 7.02%. Total Assets is also linked to Revenue through Asset Turnover. Shandong Weigao Group Medical Polymer Co's Asset Turnover for the quarter that ended in Jun. 2023 was 0.20.

Shandong Weigao Group Medical Polymer Co Total Assets Historical Data

The historical data trend for Shandong Weigao Group Medical Polymer Co's Total Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shandong Weigao Group Medical Polymer Co Total Assets Chart

Shandong Weigao Group Medical Polymer Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Total Assets

Get a 7-Day Free Trial

3,757.34

4,275.34

4,800.80

4,791.13

4,715.59

Shandong Weigao Group Medical Polymer Co Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Total Assets	Get a 7-Day Free Trial															4,800.80	4,876.77	4,791.13	4,738.70	4,715.59

Shandong Weigao Group Medical Polymer Co Total Assets Calculation

Total Assets are all the assets a company owns.

From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.

Shandong Weigao Group Medical Polymer Co's Total Assets for the fiscal year that ended in Dec. 2022 is calculated as

Total Assets	=	Total Equity (A: Dec. 2022 )	+	Total Liabilities (A: Dec. 2022 )
	=	3382.573	+	1408.56
	=	4,791

Shandong Weigao Group Medical Polymer Co's Total Assets for the quarter that ended in Jun. 2023 is calculated as

Total Assets	=	Total Equity (Q: Jun. 2023 )	+	Total Liabilities (Q: Jun. 2023 )
	=	3292.576	+	1446.124
	=	4,739

Shandong Weigao Group Medical Polymer Co (OTCPK:SHWGY) Total Assets Explanation

Total Assets is connected with ROA %.

Shandong Weigao Group Medical Polymer Co's annualized ROA % for the quarter that ended in Jun. 2023 is

ROA %	=	Net Income (Q: Jun. 2023 )	/	( (Total Assets (Q: Dec. 2022 )	+	Total Assets (Q: Jun. 2023 ))	/ count )
	=	334.506	/	( (4791.133	+	4738.7)	/ 2 )
	=	334.506	/	4764.9165
	=	7.02 %

Note: The Net Income data used here is two times the semi-annual (Jun. 2023) data.

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Total Assets is linked to total revenue through Asset Turnover.

Shandong Weigao Group Medical Polymer Co's Asset Turnover for the quarter that ended in Jun. 2023 is

	Asset Turnover
=	Revenue (Q: Jun. 2023 )	/	( (Total Assets (Q: Dec. 2022 )	+	Total Assets (Q: Jun. 2023 ))	/ count )
=	963.178	/	( (4791.133	+	4738.7)	/ 2 )
=	963.178	/	4764.9165
=	0.20

Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.

Shandong Weigao Group Medical Polymer Co Total Assets Related Terms

Thank you for viewing the detailed overview of Shandong Weigao Group Medical Polymer Co's Total Assets provided by GuruFocus.com. Please click on the following links to see related term pages.

Shandong Weigao Group Medical Polymer Co (Shandong Weigao Group Medical Polymer Co) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Shandong Weigao Group Medical Polymer Co Ltd (OTCPK:SHWGY) » Definitions » Total Assets

Comparable Companies

Traded in Other Exchanges

SHWGF:USA 01066:Hong Kong UK2:Germany

Address

No.1, Weigao Road, Torch Hi-tech Science Park, Shandong Province, Weihai, CHN

Website

https://www.weigaogroup.com

Shandong Weigao Group Medical Polymer Co Ltd functions in the healthcare sector in China. Its business mainly involves the research and development, production, and sale of single-use medical device products. The company's segments include Medical device products, Orthopaedic products, Interventional products, Pharma packaging products, Blood management products, and others. The company's products comprise consumables including infusion sets, syringes, medical needles, blood bags, prefilled syringes, wound management, blood sampling products; orthopedic materials, and blood purification consumables and equipment. The company operates in the People's Republic of China, the United States, Europe, the Middle East, and Africa, Asia, and others.

Shandong Weigao Group Medical Polymer Co (Shandong Weigao Group Medical Polymer Co) Headlines

From GuruFocus

ACell Enters Exclusive Chinese Product Supply and Distribution Agreement for Cytal and MicroMatrix Wound Management Products

By PRNewswire PRNewswire • 04-08-2019

Shandong Weigao Group Medical Polymer Co Ltd's Dividend Analysis

By GuruFocus Research • 10-26-2023